Will Near Term Clinical Trial Results Transform Treatment Options For Sarcoma Patients?
Success rates for drug development in solid tumors remain the lowest of the many therapeutic areas in medicine.
Success rates for drug development in solid tumors remain the lowest of the many therapeutic areas in medicine.